Full Text
PRO32 Extended Half-Life (EHL) Recombinant Factor VIII (RFVIII) for the Treatment of Hemophilia a in Italy: Cost of Treatment Comparison

Abstract

Authors

F. Demma G. Di Martino

Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×